Net Cash Provided by (Used in) Operating Activities |
-23.5K |
USD |
+6.64% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
26.4K |
USD |
+5.6% |
Q2 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
5B |
shares |
0% |
Q2 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
32M |
shares |
+5.75% |
Q2 2024 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
2.91K |
USD |
|
Q2 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
7.21K |
USD |
-74.9% |
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
3.68M |
USD |
+2.34% |
Q1 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
3.68M |
USD |
+2.34% |
Q1 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2023 |
Q2 2024 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2024 |
Q1 2025 |
Additional Paid in Capital |
17.3M |
USD |
+2.21% |
Q2 2024 |
Q1 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q1 2025 |
Interest Expense |
99.3K |
USD |
-40.2% |
Q2 2024 |
Q1 2025 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q1 2025 |